Garry Nolan

Early life and background

Garry Nolan (the existing record's "Gary" is a common misspelling) was born in 1961 in the United Kingdom; his family emigrated to the United States in 1963, and he grew up in Windsor, Connecticut. He studied biology at Cornell University, graduating with a BS in genetics in 1983, and earned a PhD in genetics at Stanford University in 1989 under Leonard Herzenberg, a pioneer of flow cytometry. That training mattered later: much of Nolan's career has been built on instruments that count and characterize individual cells and particles. From 1990 to 1993 he was a postdoctoral fellow with Nobel laureate David Baltimore at MIT.

Career in biomedical science

Nolan joined the Stanford School of Medicine faculty in 1993 as an assistant professor of microbiology and immunology, becoming an associate professor in 1999 and a full professor in 2009. In 2011 he was named the Rachford and Carlota A. Harris Professor. His laboratory works on autoimmunity and inflammation, cancer and leukemia, hematopoiesis, and computational "systems immunology," and is best known for pushing mass cytometry (CyTOF) and highly multiplexed tissue imaging.

He is also a serial founder. By the Wikipedia account of his career, his companies include Rigel (1996), Nodality (2003), BINA Technology (2010; acquired by Roche in 2014 for a reported $107 million), Apprise (2011), the Roche-linked Scale Bio, and Akoya Biosciences (2015), which commercializes the CODEX multiplexed imaging platform. He has published several hundred papers, holds dozens of patents, and received the U.S. Department of Defense's Teal Innovator Award in 2012 and the Hans Sigrist Prize in 2021. This record is the foundation of his standing in ufology: he is one of very few UAP-adjacent figures with a conventional, verifiable, top-tier scientific résumé.

Entry into the UAP field

The Atacama skeleton

Nolan's public association with the topic began around 2012, when he became involved in analyzing "Ata," a roughly six-inch-long mummified skeleton found in Chile's Atacama region and promoted in the 2013 film Sirius. Online speculation held that it was a non-human hominid. Nolan's team sequenced its DNA, and a 2018 paper in Genome Research, co-led with Atul Butte of UCSF, concluded that Ata was human, of Chilean ancestry, with mutations in genes associated with skeletal dysplasia and growth disorders, which explained its unusual morphology. In other words, the work deflated the alien reading.

The paper was not free of controversy. A critique led by bioarchaeologist Kristina Killgrove and co-authored by Bernardo Arriaza in the International Journal of Paleopathology argued that the specimen could be a fetus of around 15 weeks' gestation rather than a child of six to eight years, in which case its proportions reflect normal development and the genotype–phenotype links were unsound. Chile's National Monuments Council also opened an inquiry into whether the remains had been looted and smuggled out of the country, and critics noted the paper lacked an ethics or permit statement. Nolan and Butte replied that they had no reason to believe the remains were illegally acquired; the journal said the specimen's uncertain origin meant it was not human-subjects research. See coverage at GenomeWeb and Gizmodo. The episode is useful for understanding Nolan's method, a willingness to run an unglamorous test and report a mundane result, and also his exposure to criticism when fringe subjects meet formal journals.

Government approach and experiencer studies

Nolan has said that around 2013 he was approached by people representing the government and an aerospace corporation who were interested in his lab's blood-analysis capabilities in connection with medical harm said to be linked to an "anomalous craft." His own telling, in interviews with The Debrief, Vice and Stanford Magazine, is that this led to work with more than a hundred people who reported close encounters, alleged contact, or paranormal abilities such as remote viewing. His lab collected blood for CyTOF immune profiling and arranged brain MRI scans. The specific personnel, agencies and data behind the original approach have not been publicly documented; the account rests on Nolan's word.

The most-cited result he reports is anatomical: an unusually dense connection between the caudate and putamen in the basal ganglia in a subset of these subjects, a pattern he says is rare in the general population and that he has linked to intuitive, "psi-like" or heightened perceptual abilities. He has framed this as a hypothesis worth studying rather than proof, and has stressed that he cannot say whether it is cause or consequence of experiences. As far as this entry's sources show, the experiencer imaging work has not appeared as a full peer-reviewed dataset that outside labs could assess, which is the central limit on how much weight the claim can bear.

Materials analysis

In January 2022 Nolan and Jacques Vallée, with colleagues, published a paper in Progress in Aerospace Sciences describing analytic techniques for characterizing unusual materials, and applying them to fragments associated with the 1977 Council Bluffs, Iowa incident, in which a luminous red object was reported to have fallen. Using mass spectrometry and multiplex ion beam imaging, the authors reported on compositional and isotopic features. The notable finding was a cautious one: no clear departure from terrestrial isotope ratios was demonstrated. Nolan has since talked of building a shared repository of samples and standards so that claims about "anomalous materials" can be tested by independent groups. The work places him in the long tradition of physical-evidence research, including cases such as the Ubatuba magnesium fragments, which has repeatedly failed to produce an undisputed extraterrestrial artifact.

Public advocacy and the Sol Foundation

Nolan's profile rose steeply after the 2017 New York Times reporting on AATIP and again after the 2023 David Grusch congressional hearings; journalist Leslie Kean has said Nolan knows Grusch well and vouches for him. In an August 2022 hour-long interview on Tucker Carlson Tonight and at a May 2023 SALT iConnections conference, he said, in effect, that he thought it essentially certain that non-human intelligence had visited and that governments hold recovered artifacts. These were statements of personal belief about unreleased information, not published findings, and they drew the sharpest criticism from skeptics, who note that his formal publications are far more restrained than his speaking.

On 15 August 2023 he co-founded the Sol Foundation with anthropologist Peter Skafish, serving as executive director; it aims for "methodical, scientifically-robust assessment" of UAP, with a particular focus on physical materials. Its first symposium at Stanford featured former intelligence officials, Christopher Mellon, and a surprise appearance by Grusch. Nolan has also collaborated with religious studies scholar Diana Walsh Pasulka, who features him in her work on belief and technology, and he is a coauthor on a 2025 Progress in Aerospace Sciences article on the "new science" of UAP studies (arXiv:2502.06794). Wikipedia reports that in June 2026 he was named, at the White House's request, to a UAP Science Advisory Council alongside Timothy Gallaudet, Avi Loeb, and Michael Shermer; readers should check current reporting for details of that body.

Major contributions and claims

• Credibility transfer: Nolan's chief contribution may be social rather than empirical, a Stanford professor with exceptional institutional standing lending methodological legitimacy to a field long handicapped by anecdote.
• Laboratory protocols: He has pushed for chain-of-custody, shared standards and open data in studying purported physical evidence.
• Neurological hypothesis: The basal-ganglia observation in experiencers, not yet published in full.
• Deflationary results: Both the Atacama genome and the Council Bluffs analysis ended without extraordinary conclusions, which he has presented as the system working.
• Personal beliefs: Strong public statements that NHI is real and that retrieval programs exist.

Reception and criticism

Supporters regard Nolan as precisely what the field needs: a scientist who tests rather than asserts. Critics make several points. First, the gap between his cautious papers and bold interviews. Second, the Ata paper's contested interpretation and ethical-provenance problems. Third, the reliance on undisclosed "government" contacts and on testimony, notably Grusch's, that has not been publicly substantiated. Fourth, that studying self-selected experiencers invites confounds such as selection bias, expectation and unblinded imaging. Nolan has responded that he follows data where it leads and that peer-reviewed publication is the intended endpoint. The site rates him "contested" because his mainstream scientific record is excellent while his UAP-specific claims remain largely unreplicated or unpublished.

Legacy

Whatever the eventual verdict on his hypotheses, Nolan has shifted the vocabulary of UAP discussion from belief to instrumentation, and his foundation and collaborators have made materials science a recurring theme of the post-2017 "disclosure" era. His career is also a case study in the risks of that shift: the Atacama episode shows both the power of sequencing to settle sensational claims and how quickly even careful work becomes entangled in ethics, provenance and publicity.